Eos SENOLYTIX, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-06-12.
Eos SENOLYTIX, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on June 12, 2026. The filing reports $750K sold. Its industry group is Pharmaceuticals. It names Kevin Slawin (Executive Officer, Director), Frank McGuyer (Director), Jerold Winograd (Director) (SEC Form D/A, June 12, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Eos SENOLYTIX, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Eos SENOLYTIX, Inc.
Free to see. No signup.
More on the people and the money behind Eos SENOLYTIX, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Eos SENOLYTIX, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Eos SENOLYTIX, Inc. raises, hires or launches. No email unless you switch it on.
Watch Eos SENOLYTIX, Inc. →Get the full cited report on Eos SENOLYTIX, Inc.
What the filing shows about Eos SENOLYTIX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Eos SENOLYTIX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Eos SENOLYTIX, Inc.'s address as 2710 Reed Road, Suite 160, Houston, TX 77051.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Eos SENOLYTIX, Inc. →
Amended on 2026-08-27: sales commissions changed from $0 to $1,417,500. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Eos SENOLYTIX, Inc. is a registered filer with the SEC (CIK 2129803) and has filed since 2026-06-12. 1 filing is on record, the latest on 2026-06-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Eos SENOLYTIX, Inc.'s Form D of 2026-06-12 names Kevin Slawin, Frank McGuyer and Jerold Winograd as its officers, directors or promoters.
Its new offerings report $750K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $750K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Kevin Slawin is named as Executive Officer and Director on the Form D that Eos SENOLYTIX, Inc. filed with the SEC on 12 June 2026, one of 3 people that filing names.
Frank McGuyer is named as Director on the Form D that Eos SENOLYTIX, Inc. filed with the SEC on 12 June 2026, one of 3 people that filing names.
Jerold Winograd is named as Director on the Form D that Eos SENOLYTIX, Inc. filed with the SEC on 12 June 2026, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2026-06-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Eos SENOLYTIX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Eos SENOLYTIX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Eos SENOLYTIX, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Eos SENOLYTIX, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Eos SENOLYTIX, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Eos SENOLYTIX, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/eos-senolytix-inc-form-d-26073380